Page last updated: 2024-10-24

candesartan cilexetil and Chronic Kidney Failure

candesartan cilexetil has been researched along with Chronic Kidney Failure in 3 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Research Excerpts

ExcerptRelevanceReference
"Candesartan cilexetil (1 mg/kg/day) and enalapril (10 mg/kg/day) were orally administered once a day for 4 weeks (the short-term experiment) or 16 weeks (the long-term experiment) to 5/6 nephrectomized rats beginning 15 weeks after the nephrectomy, that is, after they had already showed marked proteinuria."3.70Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure. ( Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Naka, T; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y, 1999)
"In vehicle-treated rats, proteinuria, glomerulosclerosis, interstitial mononuclear cell (MNC) infiltration and interstitial fibrosis developed."1.30Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. ( Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y, 1997)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schulz, EG1
Bahri, S1
Schettler, V1
Popov, AF1
Hermann, M1
Noda, M2
Fukuda, R2
Matsuo, T2
Ohta, M2
Nagano, H2
Imura, Y2
Nishikawa, K2
Shibouta, Y2
Naka, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria[NCT00280215]Phase 30 participants (Actual)Interventional2007-12-31Withdrawn (stopped due to Inadequate number of patients, lack of funding)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for candesartan cilexetil and Chronic Kidney Failure

ArticleYear
Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre study.
    Clinical drug investigation, 2009, Volume: 29, Issue:11

    Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Hu

2009
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Kidney international. Supplement, 1997, Volume: 63

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals;

1997
Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
    Kidney international, 1999, Volume: 56, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles;

1999